Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis

Clinical trial NCT02434029 · COMPLETED

Trial details

NCT number: NCT02434029
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2015-11-11
Primary completion: 2016-08-04
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.